World's Best Scientists 2026 revealed!
Jeremy Schwartzentruber

Jeremy Schwartzentruber

D-Index & Metrics

Genetics

D-Index
65
Citations
21631
World Ranking
2666
National Ranking
338

Jeremy Schwartzentruber publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Jeremy Schwartzentruber sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 129 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Jeremy Schwartzentruber D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Jeremy Schwartzentruber sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 65 D-Index — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Jeremy Schwartzentruber is affiliated with the Wellcome Sanger Institute in the United Kingdom. Their research primarily spans the field of Biochemistry, Genetics and Molecular Biology, with a focus on Molecular Biology, Genetics, Infectious Diseases, Immunology, and Computational Theory and Mathematics.

The scientist's main research topics include Genetic Associations and Epidemiology, Bioinformatics and Genomic Networks, Genomics and Chromatin Dynamics, SARS-CoV-2 and COVID-19 Research, Genomics and Rare Diseases, CRISPR and Genetic Engineering, and Epigenetics and DNA Methylation.

Schwartzentruber has contributed to several recent publications, including the following:

  • Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer's disease risk genes, 2021, Nature Genetics
  • Mapping the human genetic architecture of COVID-19, 2021, Nature
  • Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics, 2020, Nucleic Acids Research
  • An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci, 2021, Nature Genetics
  • Open Targets Platform: supporting systematic drug-target identification and prioritisation, 2020, Nucleic Acids Research

Their frequent co-authors include:

  • Maya Ghoussaini
  • Ian Dunham
  • Mohd Anisul Karim
  • David Ochoa
  • Andrew Bassett

Jeremy Schwartzentruber's work has been published extensively in prominent venues such as bioRxiv (Cold Spring Harbor Laboratory), Nucleic Acids Research, Nature Genetics, Zenodo (CERN European Organization for Nuclear Research), and Nature.

Best Publications

  • Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

    Jeremy Schwartzentruber;Andrey Korshunov;Xiao Yang Liu;David T.W. Jones

  • Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

    Dominik Sturm;Hendrik Witt;Hendrik Witt;Volker Hovestadt;Dong Anh Khuong-Quang

  • K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas.

    Dong Anh Khuong-Quang;Pawel Buczkowicz;Patricia Rakopoulos;Xiao Yang Liu

  • Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma

    David T W Jones;Barbara Hutter;Natalie Jäger;Andrey Korshunov;Andrey Korshunov

  • De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes

    Jean Baptiste Rivière;Ghayda M. Mirzaa;Brian J. O'Roak;Margaret Beddaoui

  • Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics.

    Maya Ghoussaini;Edward Mountjoy;Miguel Carmona;Gareth Peat

  • What can exome sequencing do for you

    Jacek Majewski;Jeremy Schwartzentruber;Emilie Lalonde;Alexandre Montpetit

  • Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations.

    Xiao-Yang Liu;Noha Gerges;Andrey Korshunov;Nesrin Sabha

  • Clonal selection drives genetic divergence of metastatic medulloblastoma

    Xiaochong Wu;Paul A. Northcott;Adrian Dubuc;Adam J. Dupuy

  • Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma

    Adam M. Fontebasso;Simon Papillon-Cavanagh;Jeremy Schwartzentruber;Hamid Nikbakht

  • An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge.

    Catherine A. Brownstein;Alan H. Beggs;Nils Homer;Barry Merriman

  • Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care.

    S L Sawyer;T Hartley;D A Dyment;C L Beaulieu

  • An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci.

    Edward Mountjoy;Ellen M. Schmidt;Miguel Carmona;Jeremy Schwartzentruber;Jeremy Schwartzentruber

  • Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer’s disease risk genes

    Jeremy Schwartzentruber;Jeremy Schwartzentruber;Sarah Cooper;Jimmy Z. Liu;Inigo Barrio-Hernandez

  • Open Targets Platform: supporting systematic drug-target identification and prioritisation.

    David Ochoa;Andrew Hercules;Miguel Carmona;Daniel Suveges

  • Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas

    Adam M. Fontebasso;Jeremy Schwartzentruber;Dong Anh Khuong-Quang;Xiao Yang Liu

  • Biallelic Mutations in BRCA1 Cause a New Fanconi Anemia Subtype

    Sarah L Sawyer;Lei Tian;Marketta Kähkönen;Jeremy Schwartzentruber

  • Mutations in SYNGAP1 Cause Intellectual Disability, Autism, and a Specific Form of Epilepsy by Inducing Haploinsufficiency

    Martin H. Berryer;Fadi F. Hamdan;Laura L. Klitten;Rikke S. Møller

  • FORGE Canada Consortium: Outcomes of a 2-Year National Rare-Disease Gene-Discovery Project

    Chandree L. Beaulieu;Jacek Majewski;Jeremy Schwartzentruber;Mark E. Samuels

  • Haploinsufficiency of SF3B4, a component of the pre-mRNA spliceosomal complex, causes Nager syndrome.

    Francois P. Bernier;Oana Caluseriu;Sarah Ng;Jeremy Schwartzentruber

Frequent Co-Authors

Jacek Majewski
Jacek Majewski McGill University
Kym M. Boycott
Kym M. Boycott Children's Hospital of Eastern Ontario
Dennis E. Bulman
Dennis E. Bulman Children's Hospital of Eastern Ontario
Nada Jabado
Nada Jabado McGill University
Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
David A. Dyment
David A. Dyment University of Ottawa
A. Micheil Innes
A. Micheil Innes University of Calgary
Jacques L. Michaud
Jacques L. Michaud University of Montreal
Andrey Korshunov
Andrey Korshunov German Cancer Research Center
Mark E. Samuels
Mark E. Samuels University of Montreal

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Genetics opens doors to many related fields and online degrees that can complement your expertise. If you’re considering a broader healthcare path, there are flexible options for further study and specialization.

For those with a nursing background, the best online rn to bsn programs without clinical requirements offer a convenient route to advance your academic credentials without the need for in-person clinicals. If you already hold a master’s, upgrading to terminal degrees is possible through the shortest msn to dnp program, which emphasizes efficiency and flexibility for working professionals.

Not all roles require a long-term degree commitment. Aspiring healthcare professionals may consider a medical assistant training program, which can be completed in a matter of weeks and provides foundational skills in patient care and laboratory work. For those interested in advanced clinical leadership, exploring dnp school options can help you find accessible pathways to a Doctor of Nursing Practice degree.

These related online programs support diverse career trajectories for anyone passionate about genetics, healthcare, or biotech fields.

Best Scientists Citing Jeremy Schwartzentruber

Trending Scientists

Recently Published Articles